Pacer Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $78M | Sell |
734,579
-110,126
| -13% | -$11.7M | 0.19% | 107 |
|
|
2025
Q1 | $105M | Sell |
844,705
-1,369,775
| -62% | -$170M | 0.25% | 84 |
|
|
2024
Q4 | $273M | Buy |
2,214,480
+115,102
| +5% | +$14.2M | 0.59% | 41 |
|
|
2024
Q3 | $234M | Buy |
2,099,378
+278,465
| +15% | +$31M | 0.49% | 51 |
|
|
2024
Q2 | $194M | Buy |
1,820,913
+527,187
| +41% | +$56.3M | 0.44% | 53 |
|
|
2024
Q1 | $156M | Buy |
1,293,726
+270,020
| +26% | +$32.5M | 0.36% | 85 |
|
|
2023
Q4 | $126M | Buy |
1,023,706
+224,865
| +28% | +$27.7M | 0.36% | 76 |
|
|
2023
Q3 | $103M | Buy |
798,841
+114,552
| +17% | +$14.8M | 0.4% | 61 |
|
|
2023
Q2 | $84.8M | Buy |
684,289
+206,243
| +43% | +$25.6M | 0.34% | 64 |
|
|
2023
Q1 | $70M | Buy |
478,046
+137,586
| +40% | +$20.1M | 0.3% | 76 |
|
|
2022
Q4 | $54.2M | Buy |
340,460
+337,685
| +12,169% | +$53.8M | 0.28% | 70 |
|
|
2022
Q3 | $370K | Buy |
+2,775
| New | +$370K | ﹤0.01% | 1023 |
|
|
2022
Q1 | – | Sell |
-6,260
| Closed | -$798K | – | 2414 |
|
|
2021
Q4 | $798K | Sell |
6,260
-463
| -7% | -$59K | 0.01% | 1339 |
|
|
2021
Q3 | $875K | Sell |
6,723
-16,149
| -71% | -$2.1M | 0.01% | 921 |
|
|
2021
Q2 | $4.06M | Buy |
22,872
+16,567
| +263% | +$2.94M | 0.06% | 417 |
|
|
2021
Q1 | $1.04M | Buy |
6,305
+239
| +4% | +$39.3K | 0.02% | 759 |
|
|
2020
Q4 | $1M | Buy |
+6,066
| New | +$1M | 0.02% | 696 |
|